CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
70.12
-1.02 (-1.43%)
Oct 24, 2025, 3:59 PM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $66.83 billion as of October 24, 2025. Its market cap has decreased by -31.39% in one year.
Market Cap
66.83B
Enterprise Value
78.16B
Revenue
15.56B
Ranking
n/a
PE Ratio
22.26
Stock Price
$70.12
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 66.83B, an increase of 28,937.76%. That is a compound annual growth rate of 19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 66.86B | -20.75% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 633.13M |
| Glass House Brands | 608.71M |
| Silence Therapeutics | 340.08M |
| Nika Pharmaceuticals | 335.28M |
| Northwest Biotherapeutics | 324.50M |
| CytoDyn | 319.85M |
| American Oncology Network | 289.95M |